LEUKINE Side Effects

7013263-3 | Blood Potassium Decreased, Haematocrit Decreased, Haemoglobin Decreased, Hypothyroidism, Mental Impairment, Renal Failure, Renal Failure Acute
on Sep 13, 2010 Male patient from UNITED STATES , 71 years of age, weighting 207.2 lb, was diagnosed with glioblastoma multiforme, urinary tract infection (What is urinary tract infection?) and was treated with Leukine (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium decreased, haematocrit decreased, haemoglobin decreased, hypothyroidism, mental impairment, renal failure, renal failure acute. Leukine dosage: . During the same period patient was treated with TEMODAR (Day 1-5 Every 28 Days) (View Temodar Review and Temodar Label ), CDX 110 (View Cdx-110 Review and Cdx-110 Label ), ACYCLOVIR SODIUM (Total Daily Dose: 900 Mg) (View Acyclovir Sodium Review and Acyclovir Sodium Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), AVODART (View Avodart Review and Avodart Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

7011982-6 | Hypothyroidism, Mental Impairment, Renal Failure
Patient was taking Leukine (View Usage). Patient had the following side effects: hypothyroidism, mental impairment, renal failure on Sep 13, 2010 from UNITED STATES Additional patient health information: Male patient , 71 years of age, weighting 207.2 lb, was diagnosed with glioblastoma multiforme, urinary tract infection (What is urinary tract infection?) and. Leukine dosage: . During the same period patient was treated with TEMODAR (Day 1-5 Every 28 Days) (View Temodar Review and Temodar Label ), CDX 110 (View Cdx-110 Review and Cdx-110 Label ), ACYCLOVIR SODIUM (Total Daily Dose: 900 Mg) (View Acyclovir Sodium Review and Acyclovir Sodium Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), AVODART (View Avodart Review and Avodart Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

7004996-3 | Pancytopenia, Pyrexia
Adverse event was reported on Sep 20, 2010 by a Male patient taking Leukine (View Usage) (Dosage: 500mcg Days 3-13 Sq) was diagnosed with neutropenia and. Location: UNITED STATES , 60 years of age, weighting 196.0 lb, After Leukine was administered, patient had the following side effects: pancytopenia, pyrexia. During the same period patient was treated with COLACE (View Colace Review and Colace Label ), PEPCID (View Pepcid Review and Pepcid Label ), CARDIAZEM (View Cardiazem Review and Cardiazem Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ZOFRAN (View Zofran Review and Zofran Label ), NEURONTIN (View Neurontin Review and Neurontin Label ). Patient was hospitalized.

7004984-7 | Dyspnoea, Febrile Neutropenia, Hyperhidrosis, Tachycardia
on Sep 20, 2010 Male patient from UNITED STATES , 60 years of age, weighting 196.0 lb, was diagnosed with neutropenia and was treated with Leukine (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, febrile neutropenia, hyperhidrosis, tachycardia. Leukine dosage: 500mcg Days 3-13 Sq. During the same period patient was treated with COLACE (View Colace Review and Colace Label ), PEPCID (View Pepcid Review and Pepcid Label ), CARDIAZEM (View Cardiazem Review and Cardiazem Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CEFEPIME HYDROCHLORIDE (View Cefepime Hydrochloride Review and Cefepime Hydrochloride Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.


6969907-5 | Atrial Fibrillation
on Aug 23, 2010 Male patient from UNITED STATES , 70 years of age, was diagnosed with prostate cancer metastatic and was treated with Leukine (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?). Leukine dosage: Total Daily Dose: 250 ?g/m2. During the same period patient was treated with IPILIMUMAB (Cycle 1 / Day 1) (View Ipilimumab Review and Ipilimumab Label ), RITALIN (View Ritalin Review and Ritalin Label ).

6969906-3 | Pulmonary Embolism
Patient was taking Leukine (View Usage). After Leukine was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?) on Aug 23, 2010 from UNITED STATES Additional patient health information: Male patient , 71 years of age, was diagnosed with prostate cancer metastatic and. Leukine dosage: Days 1-14 Of Each Cycle. During the same period patient was treated with IPILIMUMAB (View Ipilimumab Review and Ipilimumab Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ). Patient was hospitalized.

6968853-0 | Pulmonary Embolism
Adverse event was reported on Aug 23, 2010 by a Male patient taking Leukine (View Usage) (Dosage: Days 1-14 Of Each Cycle) was diagnosed with prostate cancer metastatic and. Location: UNITED STATES , 71 years of age, Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with IPILIMUMAB (View Ipilimumab Review and Ipilimumab Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ). Patient was hospitalized.

6968852-9 | Atrial Fibrillation
on Aug 23, 2010 Male patient from UNITED STATES , 70 years of age, was diagnosed with prostate cancer metastatic and was treated with Leukine (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?). Leukine dosage: Total Daily Dose: 250 ?g/m2. During the same period patient was treated with IPILIMUMAB (Cycle 1 / Day 1) (View Ipilimumab Review and Ipilimumab Label ), RITALIN (View Ritalin Review and Ritalin Label ).

6880749-1 | Fatigue, Somnolence
on Jul 19, 2010 Male patient from UNITED STATES , 55 years of age, was diagnosed with white blood cell count decreased and was treated with Leukine (View Usage). After Leukine was administered, patient had the following side effects: fatigue, somnolence. Leukine dosage: Had 2 Injections Refused 3rd.. During the same period patient was treated with GEMZAR (View Gemzar Review and Gemzar Label ), PROCRIT (View Procrit Review and Procrit Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), LOTREL (10/40) (View Lotrel Review and Lotrel Label ), ACTOS (30) (View Actos Review and Actos Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), VALIUM (View Valium Review and Valium Label ).

6840146-1 | Mental Impairment, Renal Failure
Patient was taking Leukine (View Usage). Patient experienced the following unwanted or unexpected effects: mental impairment, renal failure on Jul 02, 2010 from UNITED STATES Additional patient health information: Male patient , 71 years of age, weighting 207.2 lb, was diagnosed with glioblastoma multiforme and. Leukine dosage: . During the same period patient was treated with TEMODAR (Day 1-5 Every 28 Days) (View Temodar Review and Temodar Label ), CDX 110 (View Cdx-110 Review and Cdx-110 Label ), ACYCLOVIR (Total Daily Dose: 900 Mg) (View Acyclovir Review and Acyclovir Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), AVODART (View Avodart Review and Avodart Label ), DEXAMETHASONE ACETATE (View Dexamethasone Acetate Review and Dexamethasone Acetate Label ). Patient was hospitalized.

6816605-4 | Pulmonary Embolism
Adverse event was reported on Jun 22, 2010 by a Male patient taking Leukine (View Usage) (Dosage: Days 1-14 Of Each Cycle) was diagnosed with prostate cancer metastatic and. Location: UNITED STATES , 71 years of age, Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with IPILIMUMAB (View Ipilimumab Review and Ipilimumab Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), HYDROMORPHONE (View Hydromorphone Review and Hydromorphone Label ). Patient was hospitalized.

6800714-X | Pulmonary Embolism
on Jun 22, 2010 Male patient from UNITED STATES , 71 years of age, was diagnosed with prostate cancer (What is prostate cancer?), prostate cancer metastatic and was treated with Leukine (View Usage). After Leukine was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Leukine dosage: Days 1-14 Of Each Cycle. During the same period patient was treated with IPILIMUMAB (View Ipilimumab Review and Ipilimumab Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), HYDROMORPHONE (View Hydromorphone Review and Hydromorphone Label ). Patient was hospitalized.

6761977-2 | Pulmonary Embolism
on Jun 07, 2010 Male patient from UNITED STATES , 77 years of age, weighting 242.5 lb, was diagnosed with malignant melanoma and was treated with Leukine (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?). Leukine dosage: Total Daily Dose: 125 ?g/m2. During the same period patient was treated with LISINOPRIL (Total Daily Dose: 2.5 Mg) (View Lisinopril Review and Lisinopril Label ), FLOMAX (Total Daily Dose: 0.4 Mg) (View Flomax Review and Flomax Label ), ASPIRIN (Total Daily Dose: 81 Mg) (View Aspirin Review and Aspirin Label ), XANAX (0.25mg) (View Xanax Review and Xanax Label ). Patient was hospitalized.

6750894-X | Acute Lung Injury, Dehydration, Device Related Infection, Diarrhoea, Gastritis, Pneumomediastinum, Pneumonia, Pneumothorax, Respiratory Failure
Patient was taking Leukine (View Usage). Patient had the following side effects: acute lung injury, dehydration, device related infection, diarrhoea, gastritis, pneumomediastinum, pneumonia (What is pneumonia?), pneumothorax, respiratory failure on May 28, 2010 from PUERTO RICO Additional patient health information: Female patient , 60 years of age, weighting 121.3 lb, was diagnosed with diffuse large b-cell lymphoma and. Leukine dosage: Day 3 Cycle 2 To Be Given X 4 Days. During the same period patient was treated with RITUXIMAB (Day 1 Cycle 3) (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6743168-4 | Bacteraemia, Dehydration, Diarrhoea, Gastritis, Septic Shock
Adverse event was reported on May 19, 2010 by a Female patient taking Leukine (View Usage) (Dosage: Day 3 Cycle 3 To Be Given X 4 Days) was diagnosed with diffuse large b-cell lymphoma and. Location: PUERTO RICO , 60 years of age, weighting 121.3 lb, After Leukine was administered, patient had the following side effects: bacteraemia, dehydration, diarrhoea, gastritis, septic shock. During the same period patient was treated with RITUXIMAB (Day 1 Cycle 5) (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6730594-2 | Mental Impairment, Renal Failure
on May 10, 2010 Male patient from UNITED STATES , 70 years of age, weighting 207.2 lb, was diagnosed with glioblastoma multiforme and was treated with Leukine (View Usage). Patient experienced the following unwanted or unexpected effects: mental impairment, renal failure. Leukine dosage: . During the same period patient was treated with TEMODAR (Day 1-5 Every 28 Days) (View Temodar Review and Temodar Label ), CDX 110 (View Cdx-110 Review and Cdx-110 Label ), ACYCLOVIR (Total Daily Dose: 900 Mg) (View Acyclovir Review and Acyclovir Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), AVODART (View Avodart Review and Avodart Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6727342-9 | Mental Impairment, Renal Failure
on May 10, 2010 Male patient from UNITED STATES , 70 years of age, weighting 207.2 lb, was diagnosed with glioblastoma multiforme and was treated with Leukine (View Usage). Patient had the following side effects: mental impairment, renal failure. Leukine dosage: . During the same period patient was treated with TEMODAR (Day 1-5 Every 28 Days) (View Temodar Review and Temodar Label ), CDX 110 (View Cdx-110 Review and Cdx-110 Label ), ACYCLOVIR (Total Daily Dose: 900 Mg) (View Acyclovir Review and Acyclovir Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), AVODART (View Avodart Review and Avodart Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6725140-3 | Mental Impairment, Renal Failure
Patient was taking Leukine (View Usage). After Leukine was administered, patient had the following side effects: mental impairment, renal failure on May 05, 2010 from UNITED STATES Additional patient health information: Male patient , 70 years of age, weighting 207.2 lb, was diagnosed with glioblastoma multiforme and. Leukine dosage: . During the same period patient was treated with TEMODAR (Day 1-5 Every 28 Days) (View Temodar Review and Temodar Label ), CDX 110 (View Cdx-110 Review and Cdx-110 Label ), ACYCLOVIR (Total Daily Dose: 900 Mg) (View Acyclovir Review and Acyclovir Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), AVODART (View Avodart Review and Avodart Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6721167-6 | Blood Potassium Decreased, Haematocrit Decreased, Haemoglobin Decreased, Mental Impairment, Renal Failure
Adverse event was reported on May 05, 2010 by a Male patient taking Leukine (View Usage) (Dosage: ) was diagnosed with glioblastoma multiforme and. Location: UNITED STATES , 70 years of age, weighting 207.2 lb, Patient experienced the following unwanted or unexpected effects: blood potassium decreased, haematocrit decreased, haemoglobin decreased, mental impairment, renal failure. During the same period patient was treated with TEMODAR (Day 1-5 Every 28 Days) (View Temodar Review and Temodar Label ), CDX 110 (View Cdx-110 Review and Cdx-110 Label ), ACYCLOVIR (Total Daily Dose: 900 Mg) (View Acyclovir Review and Acyclovir Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), AVODART (View Avodart Review and Avodart Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6712644-2 | Pulmonary Embolism
on May 03, 2010 Male patient from UNITED STATES , 77 years of age, weighting 242.5 lb, was diagnosed with malignant melanoma and was treated with Leukine (View Usage). Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Leukine dosage: Total Daily Dose: 125 ?g/m2. During the same period patient was treated with LISINOPRIL (Total Daily Dose: 2.5 Mg) (View Lisinopril Review and Lisinopril Label ), FLOMAX (Total Daily Dose: 0.4 Mg) (View Flomax Review and Flomax Label ), ASPIRIN (Total Daily Dose: 81 Mg) (View Aspirin Review and Aspirin Label ), XANAX (0.25mg) (View Xanax Review and Xanax Label ). Patient was hospitalized.

6709045-X | Pulmonary Embolism
on Apr 27, 2010 Male patient from UNITED STATES , 77 years of age, weighting 242.5 lb, was diagnosed with malignant melanoma and was treated with Leukine (View Usage). After Leukine was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Leukine dosage: Total Daily Dose: 125 ?g/m2. During the same period patient was treated with LISINOPRIL (Total Daily Dose: 2.5 Mg) (View Lisinopril Review and Lisinopril Label ), FLOMAX (Total Daily Dose: 0.4 Mg) (View Flomax Review and Flomax Label ), ASPIRIN (Total Daily Dose: 81 Mg) (View Aspirin Review and Aspirin Label ), XANAX (0.25mg) (View Xanax Review and Xanax Label ). Patient was hospitalized.

6709043-6 | No Adverse Event
Patient was taking Leukine (View Usage). Patient experienced the following unwanted or unexpected effects: no adverse event on Apr 20, 2010 from UNITED STATES Additional patient health information: Male patient , 69 years of age, was diagnosed with neutropenia and. Leukine dosage: .

6704070-7 | Blood Creatinine Increased, Glomerular Filtration Rate Decreased
Adverse event was reported on Feb 25, 2010 by a Female patient taking Leukine (View Usage) (Dosage: 2 Weeks On And 2 Weeks Off For Approx 18 Months) was diagnosed with malignant melanoma and. Location: UNITED STATES , 83 years of age, Patient had the following side effects: blood creatinine increased, glomerular filtration rate decreased. During the same period patient was treated with ACE INHIBITOR (View Ace Inhibitor Review and Ace Inhibitor Label ), CT SCAN CONTRAST DYE (View Ct Scan Contrast Dye Review and Ct Scan Contrast Dye Label ).

6704023-9 | Dehydration, Diarrhoea, Gastritis
on Apr 22, 2010 Female patient from PUERTO RICO , 60 years of age, weighting 121.3 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Leukine (View Usage). After Leukine was administered, patient had the following side effects: dehydration, diarrhoea, gastritis. Leukine dosage: Day 3 Cycle 4 To Be Given X 4 Days. During the same period patient was treated with RITUXIMAB (Day 1 Cycle 4) (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6702103-5 | Injection Site Erythema
on Mar 01, 2010 Male patient from UNITED STATES , 60 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Leukine (View Usage). Patient experienced the following unwanted or unexpected effects: injection site erythema. Leukine dosage: .

6701803-0 | Inhibiting Antibodies, Injection Site Erythema
Patient was taking Leukine (View Usage). Patient had the following side effects: inhibiting antibodies, injection site erythema on Apr 16, 2010 from UNITED STATES Additional patient health information: Male patient , 63 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Leukine dosage: 3 Years At All, Initially 90 Days Then 30 Days Every 6 Month.

6696236-X | Dehydration, Diarrhoea, Gastritis
Adverse event was reported on Apr 16, 2010 by a Female patient taking Leukine (View Usage) (Dosage: Day 3 Cycle 1 To Be Given X 4 Days) was diagnosed with diffuse large b-cell lymphoma and. Location: PUERTO RICO , 60 years of age, weighting 121.3 lb, After Leukine was administered, patient had the following side effects: dehydration, diarrhoea, gastritis. During the same period patient was treated with RITUXIMAB (Day 1 Cycle 3) (View Rituximab Review and Rituximab Label ), CYCLOPHOSPHAMIDE (Day 2 Cycle 3) (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6688278-5 | Asthenia, Bone Pain, Constipation, Musculoskeletal Discomfort, Red Blood Cell Count Decreased
on Feb 11, 2010 Male patient from UNITED STATES , 83 years of age, was diagnosed with myelodysplastic syndrome and was treated with Leukine (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, bone pain, constipation (What is constipation?), musculoskeletal discomfort, red blood cell count decreased. Leukine dosage: Daily For 2 Days Following 5 Days Of Vidazia Each Month. During the same period patient was treated with VIDAZA (As Used: 150 Mg) (View Vidaza Review and Vidaza Label ), JOINT ADVANTAGE (View Joint Advantage Review and Joint Advantage Label ), PROBOTIC ADVANTAGE (View Probotic Advantage Review and Probotic Advantage Label ).

6672630-8 | Pulmonary Embolism
on Apr 02, 2010 Male patient from UNITED STATES , 77 years of age, weighting 242.5 lb, was diagnosed with malignant melanoma and was treated with Leukine (View Usage). Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Leukine dosage: Total Daily Dose: 125 ?g/m2. During the same period patient was treated with LISINOPRIL (Total Daily Dose: 2.5 Mg) (View Lisinopril Review and Lisinopril Label ), FLOMAX (Total Daily Dose: 0.4 Mg) (View Flomax Review and Flomax Label ), ASPIRIN (Total Daily Dose: 81 Mg) (View Aspirin Review and Aspirin Label ), XANAX (0.25mg) (View Xanax Review and Xanax Label ). Patient was hospitalized.

6663430-3 | Pulmonary Embolism
Patient was taking Leukine (View Usage). After Leukine was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?) on Mar 29, 2010 from UNITED STATES Additional patient health information: Male patient , 77 years of age, weighting 242.5 lb, was diagnosed with malignant melanoma and. Leukine dosage: Total Daily Dose: 125 ?g/m2. During the same period patient was treated with LISINOPRIL (Total Daily Dose: 2.5 Mg) (View Lisinopril Review and Lisinopril Label ), FLOMAX (Total Daily Dose: 0.4 Mg) (View Flomax Review and Flomax Label ), ASPIRIN (Total Daily Dose: 81 Mg) (View Aspirin Review and Aspirin Label ), XANAX (0.25mg) (View Xanax Review and Xanax Label ). Patient was hospitalized.

6653145-X | Pulmonary Embolism
Adverse event was reported on Mar 23, 2010 by a Male patient taking Leukine (View Usage) (Dosage: Total Daily Dose: 125 ?g/m2) was diagnosed with malignant melanoma and. Location: UNITED STATES , 77 years of age, weighting 242.5 lb, Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FLOMAX (View Flomax Review and Flomax Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), XANAX (View Xanax Review and Xanax Label ), CENTRUM SILVER (View Centrum Silver Review and Centrum Silver Label ), SLOW FE (View Slow-fe Review and Slow-fe Label ). Patient was hospitalized.

6617864-3 | Pulmonary Embolism
on Feb 24, 2010 Male patient from UNITED STATES , 77 years of age, weighting 242.5 lb, was diagnosed with malignant melanoma and was treated with Leukine (View Usage). Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Leukine dosage: Total Daily Dose: 125 ?g/m2. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FLOMAX (View Flomax Review and Flomax Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), XANAX (View Xanax Review and Xanax Label ), CENTRUM SILVER (View Centrum Silver Review and Centrum Silver Label ), SLOW FE (View Slow-fe Review and Slow-fe Label ). Patient was hospitalized.

6611597-5 | Pulmonary Embolism
on Feb 19, 2010 Male patient from UNITED STATES , 77 years of age, weighting 242.5 lb, was diagnosed with malignant melanoma and was treated with Leukine (View Usage). After Leukine was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Leukine dosage: Total Daily Dose: 125 ?g/m2. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FLOMAX (View Flomax Review and Flomax Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), XANAX (View Xanax Review and Xanax Label ), CENTRUM SILVER (View Centrum Silver Review and Centrum Silver Label ), SLOW FE (View Slow-fe Review and Slow-fe Label ), VITAMIN C (View Vitamin C Review and Vitamin C Label ). Patient was hospitalized.

6571916-5 | Anaemia, Cellulitis, Dehydration, Diabetes Mellitus Inadequate Control, Diarrhoea, Febrile Neutropenia, Head Injury, Mucosal Inflammation
Patient was taking Leukine (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, cellulitis (What is cellulitis?), dehydration, diabetes mellitus inadequate control, diarrhoea, febrile neutropenia, head injury, mucosal inflammation on Jan 25, 2010 from PUERTO RICO Additional patient health information: Male patient , 74 years of age, weighting 130.1 lb, was diagnosed with diffuse large b-cell lymphoma and. Leukine dosage: Day 3 Cycle 5 To Be Given X4 Days. During the same period patient was treated with RITUXIMAB (Day 1 Cycle 3) (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6571902-5 | Acute Myocardial Infarction, Hypotension
Adverse event was reported on Feb 01, 2010 by a Male patient taking Leukine (View Usage) (Dosage: ) was diagnosed with neutropenia, diabetes mellitus and. Location: UNITED STATES , 62 years of age, Patient had the following side effects: acute myocardial infarction, hypotension. During the same period patient was treated with METFORMIN HCL (Total Daily Dose: 1000 Mg) (View Metformin Hcl Review and Metformin Hcl Label ), INSULIN (70/30) (View Insulin Review and Insulin Label ). Patient was hospitalized.

6541627-0 | Anaemia, Cellulitis, Dehydration, Diabetes Mellitus Inadequate Control, Diarrhoea, Febrile Neutropenia, Head Injury, Mucosal Inflammation
on Jan 08, 2010 Male patient from PUERTO RICO , 74 years of age, weighting 130.1 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Leukine (View Usage). After Leukine was administered, patient had the following side effects: anaemia, cellulitis (What is cellulitis?), dehydration, diabetes mellitus inadequate control, diarrhoea, febrile neutropenia, head injury, mucosal inflammation. Leukine dosage: Day 3 Cycle 4 To Be Given X4 Days. During the same period patient was treated with RITUXIMAB (Day 1 Cycle 1) (View Rituximab Review and Rituximab Label ), CYCLOPHOSPHAMIDE (Day 2 Cycle4) (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6501467-5 | Autonomic Nervous System Imbalance, Immunodeficiency
on Dec 01, 2009 Male patient from FRANCE , 49 years of age, was diagnosed with idiopathic pulmonary fibrosis, pain (What is pain?) and was treated with Leukine (View Usage). Patient experienced the following unwanted or unexpected effects: autonomic nervous system imbalance, immunodeficiency. Leukine dosage: Unit Dose: 500 ?g/ml. During the same period patient was treated with DI ANTALVIC (View Di-antalvic Review and Di-antalvic Label ), PROZAC (View Prozac Review and Prozac Label ).

6497539-4 | Anaemia, Cellulitis, Diarrhoea, Febrile Neutropenia, Mucosal Inflammation, Postoperative Wound Infection, Sepsis Syndrome, Thrombocytopenia
Patient was taking Leukine (View Usage). Patient had the following side effects: anaemia, cellulitis (What is cellulitis?), diarrhoea, febrile neutropenia, mucosal inflammation, postoperative wound infection, sepsis syndrome, thrombocytopenia on Dec 03, 2009 from PUERTO RICO Additional patient health information: Male patient , 74 years of age, weighting 141.1 lb, was diagnosed with diffuse large b-cell lymphoma and. Leukine dosage: Day 3 Cycle 3 To Be Given X4 Days. During the same period patient was treated with RITUXIMAB (Day 1 Cycle3) (View Rituximab Review and Rituximab Label ), CYCLOPHOSPHAMIDE (Day 2 Cycle 2) (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6490433-4 | Autonomic Nervous System Imbalance, Immunodeficiency
Adverse event was reported on Dec 01, 2009 by a Male patient taking Leukine (View Usage) (Dosage: Unit Dose: 500 ?g/ml) was diagnosed with idiopathic pulmonary fibrosis, pain (What is pain?) and. Location: FRANCE , 49 years of age, After Leukine was administered, patient had the following side effects: autonomic nervous system imbalance, immunodeficiency. During the same period patient was treated with DI ANTALVIC (View Di-antalvic Review and Di-antalvic Label ), PROZAC (View Prozac Review and Prozac Label ).

6405033-1 | Back Pain, Cough, Dyspnoea, Oedema Peripheral, Performance Status Decreased
on Sep 29, 2009 Male patient from UNITED STATES , 73 years of age, weighting 218.3 lb, was diagnosed with malignant melanoma and was treated with Leukine (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), cough, dyspnoea, oedema peripheral, performance status decreased. Leukine dosage: As Used: 250 ?g. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VYTORIN (View Vytorin Review and Vytorin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), MIRAPEX (View Mirapex Review and Mirapex Label ).

6368728-4 | Anaphylactic Reaction, Dizziness, Dyspnoea, Hypotension, Nausea, Syncope
on Sep 15, 2009 Male patient from UNITED STATES , 55 years of age, weighting 209.4 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Leukine (View Usage). Patient had the following side effects: anaphylactic reaction, dizziness (What is dizziness?), dyspnoea, hypotension, nausea (What is nausea?), syncope. Leukine dosage: X 14 Days. Patient was hospitalized.

6339494-3 | Anaphylactic Shock, Eye Swelling, Pharyngeal Oedema
Patient was taking Leukine (View Usage). After Leukine was administered, patient had the following side effects: anaphylactic shock, eye swelling, pharyngeal oedema on Aug 26, 2009 from UNITED STATES Additional patient health information: Female patient , 60 years of age, was diagnosed with breast cancer female and. Leukine dosage: Formulation Liquid 500 Mcg/ml. During the same period patient was treated with TAXOL (As Used: 120 Mg/m2) (View Taxol Review and Taxol Label ). Patient was hospitalized.

6301419-4 | Anaphylactic Shock, Eye Swelling, Pharyngeal Oedema
Adverse event was reported on Jul 30, 2009 by a Female patient taking Leukine (View Usage) (Dosage: Formulation Liquid 500 Mcg/ml) was diagnosed with breast cancer female and. Location: UNITED STATES , 60 years of age, Patient experienced the following unwanted or unexpected effects: anaphylactic shock, eye swelling, pharyngeal oedema. Patient was hospitalized.

6292539-1 | Melanoma Recurrent, Metastatic Malignant Melanoma
on Jul 28, 2009 Male patient from UNITED STATES , 59 years of age, weighting 229.3 lb, was diagnosed with melanoma recurrent and was treated with Leukine (View Usage). Patient had the following side effects: melanoma recurrent, metastatic malignant melanoma. Leukine dosage: .

6249163-6 | Melanoma Recurrent, Metastatic Malignant Melanoma
on Jun 11, 2009 Male patient from UNITED STATES , 59 years of age, weighting 229.3 lb, was diagnosed with melanoma recurrent and was treated with Leukine (View Usage). After Leukine was administered, patient had the following side effects: melanoma recurrent, metastatic malignant melanoma. Leukine dosage: .

6248583-3 | Dyspnoea, Nausea
Patient was taking Leukine (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, nausea (What is nausea?) on Jun 24, 2009 from UNITED STATES Additional patient health information: Female patient , 50 years of age, was diagnosed with acute myeloid leukaemia and. Leukine dosage: 500 Mcg Sq X 1. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), CALCIUM (View Calcium Review and Calcium Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ).

6246614-8 | Melanoma Recurrent, Metastatic Malignant Melanoma
Adverse event was reported on Jun 11, 2009 by a Male patient taking Leukine (View Usage) (Dosage: ) was diagnosed with melanoma recurrent and. Location: UNITED STATES , 59 years of age, weighting 229.3 lb, Patient had the following side effects: melanoma recurrent, metastatic malignant melanoma.

6232530-4 | Ocular Hyperaemia, Ulcerative Keratitis
on Jun 08, 2009 Male patient from UNITED STATES , 53 years of age, was diagnosed with malignant melanoma and was treated with Leukine (View Usage). After Leukine was administered, patient had the following side effects: ocular hyperaemia, ulcerative keratitis. Leukine dosage: Total Daily Dose: 250 ?g/kg.

6192599-2 | Dizziness, Headache, Metastatic Malignant Melanoma
on May 06, 2009 Female patient from UNITED STATES , 77 years of age, weighting 125.7 lb, was diagnosed with malignant melanoma and was treated with Leukine (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), headache (What is headache?), metastatic malignant melanoma. Leukine dosage: Unit Dose: 250 ?g/m2. During the same period patient was treated with LIPITOR (Unit Dose: 10 Mg) (View Lipitor Review and Lipitor Label ), FOSAMAX (Unit Dose: 70 Mg) (View Fosamax Review and Fosamax Label ), VITAMIN E (Unk, 1x/day) (View Vitamin E Review and Vitamin E Label ), VITAMIN B6 (Unk, 1x/day) (View Vitamin B6 Review and Vitamin B6 Label ), VITAMIN B 12 (Unk, 1x/day) (View Vitamin B-12 Review and Vitamin B-12 Label ), CALCIUM WITH VITAMIN D (Unk, 1x/day) (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ), ASCORBIC ACID (Unk, 1x/day) (View Ascorbic Acid Review and Ascorbic Acid Label ), GLUCOSAMINE W/CHONDROITIN SULFATES (500/400 Mg) (View Glucosamine W/chondroitin Sulfates Review and Glucosamine W/chondroitin Sulfates Label ).

6177437-6 | Anaphylactic Reaction, Dyspnoea, Flushing, Hypoaesthesia Oral, Respiratory Arrest, Syncope
Patient was taking Leukine (View Usage). Patient had the following side effects: anaphylactic reaction, dyspnoea, flushing, hypoaesthesia oral, respiratory arrest, syncope on Apr 23, 2009 from UNITED STATES Additional patient health information: Male patient , 76 years of age, was diagnosed with myelodysplastic syndrome and. Leukine dosage: Total Daily Dose: 500 ?g.